Notice: This company has been marked as potentially delisted and may not be actively trading. Seneca Biopharma (SNCA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends SNCA vs. MGX, ACOG, ELUT, ADVM, HLVX, ABOS, DBVT, ALGS, TARA, and TNYAShould you be buying Seneca Biopharma stock or one of its competitors? The main competitors of Seneca Biopharma include Metagenomi (MGX), Alpha Cognition (ACOG), Elutia (ELUT), Adverum Biotechnologies (ADVM), HilleVax (HLVX), Acumen Pharmaceuticals (ABOS), DBV Technologies (DBVT), Aligos Therapeutics (ALGS), Protara Therapeutics (TARA), and Tenaya Therapeutics (TNYA). These companies are all part of the "medical" sector. Seneca Biopharma vs. Metagenomi Alpha Cognition Elutia Adverum Biotechnologies HilleVax Acumen Pharmaceuticals DBV Technologies Aligos Therapeutics Protara Therapeutics Tenaya Therapeutics Seneca Biopharma (NASDAQ:SNCA) and Metagenomi (NASDAQ:MGX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends, community ranking and institutional ownership. Do analysts rate SNCA or MGX? Metagenomi has a consensus price target of $16.67, indicating a potential upside of 484.80%. Given Metagenomi's stronger consensus rating and higher possible upside, analysts clearly believe Metagenomi is more favorable than Seneca Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Seneca Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Metagenomi 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Do institutionals & insiders have more ownership in SNCA or MGX? 5.2% of Seneca Biopharma shares are held by institutional investors. 2.1% of Seneca Biopharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has preferable earnings & valuation, SNCA or MGX? Seneca Biopharma has higher earnings, but lower revenue than Metagenomi. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSeneca Biopharma$10K2,473.33-$8.35MN/AN/AMetagenomi$55.08M1.94-$68.25MN/AN/A Does the media refer more to SNCA or MGX? In the previous week, Metagenomi had 5 more articles in the media than Seneca Biopharma. MarketBeat recorded 5 mentions for Metagenomi and 0 mentions for Seneca Biopharma. Metagenomi's average media sentiment score of 0.93 beat Seneca Biopharma's score of 0.00 indicating that Metagenomi is being referred to more favorably in the news media. Company Overall Sentiment Seneca Biopharma Neutral Metagenomi Positive Is SNCA or MGX more profitable? Metagenomi has a net margin of -134.27% compared to Seneca Biopharma's net margin of -230.34%. Metagenomi's return on equity of -43.23% beat Seneca Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Seneca Biopharma-230.34% -122.20% -110.61% Metagenomi -134.27%-43.23%-18.86% Does the MarketBeat Community prefer SNCA or MGX? Metagenomi received 5 more outperform votes than Seneca Biopharma when rated by MarketBeat users. Likewise, 95.00% of users gave Metagenomi an outperform vote while only 63.64% of users gave Seneca Biopharma an outperform vote. CompanyUnderperformOutperformSeneca BiopharmaOutperform Votes1463.64% Underperform Votes836.36% MetagenomiOutperform Votes1995.00% Underperform Votes15.00% SummaryMetagenomi beats Seneca Biopharma on 11 of the 15 factors compared between the two stocks. Get Seneca Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SNCA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNCA vs. The Competition Export to ExcelMetricSeneca BiopharmaBiological Products, Except Diagnostic IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.73M$3.09B$5.61B$9.14BDividend YieldN/A1.87%5.36%3.98%P/E RatioN/A46.7489.6917.66Price / Sales2,473.33297.571,219.4081.09Price / CashN/A188.8944.3437.71Price / Book1.084.145.134.73Net Income-$8.35M-$40.99M$118.85M$225.42M Seneca Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNCASeneca BiopharmaN/A$1.43flatN/A+49.0%$24.73M$10,000.000.007Gap UpMGXMetagenomi1.7572 of 5 stars$2.77-6.7%$16.67+501.7%N/A$103.65M$44.76M0.00236ACOGAlpha CognitionN/A$6.41-2.1%N/AN/A$102.69MN/A-2.50N/ANews CoverageHigh Trading VolumeELUTElutia3.3986 of 5 stars$2.95-5.8%$10.00+239.0%-17.1%$101.95M$24.75M-1.13180Short Interest ↑Positive NewsADVMAdverum Biotechnologies3.9053 of 5 stars$4.78+6.5%$27.83+482.3%-58.4%$99.42M$3.60M-0.80190News CoveragePositive NewsHLVXHilleVax2.4777 of 5 stars$1.94-1.5%$3.00+54.6%-85.9%$98.12MN/A-0.6320Short Interest ↑Gap UpABOSAcumen Pharmaceuticals2.7936 of 5 stars$1.62-1.8%$9.33+476.1%-52.6%$97.33MN/A-1.1720Short Interest ↑DBVTDBV Technologies3.5475 of 5 stars$4.52+4.1%$22.50+397.8%-51.0%$92.98M$15.73M-1.0080ALGSAligos Therapeutics4.3481 of 5 stars$25.67-15.6%$75.00+192.2%+37.6%$92.16M$15.53M-1.9390Short Interest ↑News CoverageTARAProtara Therapeutics3.4066 of 5 stars$4.45-1.8%$22.67+409.4%+67.9%$91.80MN/A-1.5830Short Interest ↓TNYATenaya Therapeutics3.7669 of 5 stars$1.14-5.8%$17.33+1,420.5%-75.6%$90.31MN/A-0.79110Gap Down Related Companies and Tools Related Companies Metagenomi Alternatives Alpha Cognition Alternatives Elutia Alternatives Adverum Biotechnologies Alternatives HilleVax Alternatives Acumen Pharmaceuticals Alternatives DBV Technologies Alternatives Aligos Therapeutics Alternatives Protara Therapeutics Alternatives Tenaya Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SNCA) was last updated on 1/31/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seneca Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seneca Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
